What You Should Know: - Propeller Health announced it will co-package a new asthma medication from Novartis, which was approved by the European Commission this week for use in the EU. - Enerzair® Breezhaler® plus Propeller Health sensor is the first asthma medication to be co-packaged and co-prescribed with a digital health platform. - Propeller’s solution works by attaching a sensor to the Enerzair® Breezhaler® inhaler, which then delivers objective data on medication use to the
Read More
Novartis
Propeller to Connect AstraZeneca’s Inhaler Symbicort Users to Propeller Platform
What You Should Know: Propeller Health has been awarded FDA 510(k) clearance to connect patients using AstraZeneca’s Symbicort Inhaler to Propeller, enhancing medication coverage and respiratory digital health. The sensor for Symbicort, a controller medication for asthma and COPD, was developed in partnership with AstraZeneca. With this new medication on our roster, Propeller now connects to 90 percent of the inhaled medications for asthma and COPD on the U.S. market. Propeller
Read More
Healthcare Data Platform H1 Raises $12.9M to Fuel Growth
What You Should Know: - H1, the biggest database in the world connecting healthcare, life science professionals, and companies raises $12.9M in funding. - Its healthcare data platform provides comprehensive in-depth profiles of more than 8 million healthcare professionals and 16,000 institutions in 70+ countries, all of which are kept up-to-date weekly. The platform enables users to understand and analyze any healthcare professional’s full profile, including expertise, interests,
Read More
Microsoft Launches $40M, 5-Year AI for Health Initiative to Advance Health Globally
- Microsoft launches 5-year, $40M AI for Health initiative to advance the health of people and communities around the world through artificial intelligence (AI). - AI for Health will focus on three core areas: quest for discovery, global health insights, and health equity. Microsoft Corporation, today announced the launch of AI for Health, a new $40M, five-year program to empower researchers and organizations with AI to improve the health of people and communities around the
Read More
Novartis to Establish AI Innovation Lab, Taps Microsoft As Strategic AI & Data Science Partner
- Novartis to establish the Novaris AI innovation lab and has formed a strategic partnership with Microsoft as its AI and data science partner. - AI Innovation lab will leverage Novartis datasets with Microsoft’s advanced AI solutions, the lab will aim to create new AI models and applications to transform medicine. - Novartis and Microsoft's strategic alliance will focus on the two core objectives of AI Empowerment and AI Exploration. Novartis announced the formation of
Read More
StartUp Health Adds 6 New Healthcare Transformers to its Portfolio
StartUp Health, a platform where health transformers, partners, customers, investors, patients, and caregivers connect and accelerate the progress of the health moonshots announced it has added six new companies to its army of Healthcare Transformers.Every quarter, StartUp Health coaches its army of Health Transformers on how to create value, amplify their story, and ultimately achieve their Health Moonshot. Each company is supported for the entire journey of their business, through multiple
Read More
Digital Prescribing Platform Xealth Raises Additional $3M to Close $14M Series A Round
Xealth, a Seattle-based digital prescribing platform has raised an additional $3 million in its Series A financing, bringing the amount raised in this round to $14 million total. New investors Atrium Health, Cleveland Clinic and MemorialCare Innovation Fund join McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network. Investments from this round will be used to advance the
Read More
Bioelectronic Medicine Startup Cala Health Nabs $50M for Wearable Neuromodulation Therapies
Cala Health, Inc., a San Francisco, CA-based bioelectronic medicine company developing wearable therapies for chronic disease has raised $50 million in Series C funding. New investors in the Series C funding round include Novartis, Baird Capital, LifeSci Venture Partners, TriVentures, and others. All existing investors participated in the round, including Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital, and
Read More
StartUp Health Adds 11 New Startups to Army of Healthcare Transformers
StartUp Health, a platform where health transformers, partners, customers, investors, patients, and caregivers connect and accelerate the progress of the health moonshots.Here is a look at the 11 new members of Startup Health’s global army of healthcare transformers:1. Cityblock Health: Iyah Romm (Co-Founder & CEO)Cityblock is a Brooklyn, NY-based company building sustainable, scalable systems that provide high-quality, cost-effective care for underserved populations with complex health
Read More
PathAI Lands $60M to Accelerate AI-Powered Pathology Platform
PathAI, a Boston, MA-based provider of AI-powered pathology platform has raised $60M in Series B funding led by General Atlantic with strong participation from General Catalyst and other existing investors. General Atlantic Managing Director Dr. Michelle Dipp will be joining PathAI’s board of directors.Advanced Learning Towards Faster More Accurate Diagnosis of DiseaseCo-founded by Chief Executive Officer Dr. Andy Beck in 2016 with the mission to offer faster, safer and more powerful solutions
Read More
